Esaote Launches Crystaline Ultrasound Technology at ECR 2014

March 5, 2014 — Esaote has launched CrystaLine, a significant evolution of its ultrasound technology that delivers new levels of accuracy, quality, versatility and value. Esaote will showcase the new technology at the 2014 annual meeting of the European Congress of Radiology in Vienna, March 6-10.

CrystaLine’s technical capabilities enable high-quality images to be captured at greater depth in the body. This significant improvement overcomes the challenges associated with larger and more technically difficult to scan patients.

CrystaLine incorporates specific hardware and software features that build on the advanced eHD ultrasound technology Esaote introduced last year. The reality of higher quality, clearer imaging at increased depth, now enables clinicians to confidently use ultrasound in borderline examinations and interventional ultrasound procedures. 

Carlos Faustmann, Esaote’s chief global marketing and domestic sales officer, said, “Ultrasound is highly valued for its safe, noninvasive nature, and continues to evolve and prove its value. One of the challenges has been capturing high-quality images in those technically difficult patients. CrystaLine changes that.”

Technical improvements provided by CrystaLine include combined pulse imaging technology, which effectively increases depth-of-field, improving the imaging of structures deeper in the body. Combined with the new XView+ speckle-noise reduction system, fully adjustable by the operator, it helps to produce an optimal personalized image.

Esaote systems with CrystaLine are also able to synchronize in real-time with therapeutic applications such as Echolaser to guide laser ablation and other procedures. “CrystaLine enables clinicians to synchronize with interventional systems such as medical lasers,” said Faustmann. “This feature plus the introduction of the 0 degrees biopsy-interventional dedicated probe, is an example of the huge potential for Esaote and ultrasound in direct therapeutic applications.”

CrystaLine is available across Esaote’s MyLabTwice, Seven and Alpha ultrasound systems.

For more information: www.esaote.com


Related Content

News | Contrast Media

April 24, 2024 — The International Contrast Ultrasound Society (ICUS) and Northwest Imaging Forums (NWIF) announced an ...

Time April 24, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

April 8, 2024 — Magnetic resonance-guided focused ultrasound (MRgFUS) is a non-invasive technique for neuroregulation ...

Time April 08, 2024
arrow
News | Radiology Business

April 4, 2024 — FUJIFILM Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging ...

Time April 04, 2024
arrow
News | Radiation Oncology

April 2, 2024 — In a 10-center study, microwave ablation offered progression free survival rates and fewer complications ...

Time April 02, 2024
arrow
News | Coronavirus (COVID-19)

March 21, 2024 — Artificial intelligence can spot COVID-19 in lung ultrasound images much like facial recognition ...

Time March 21, 2024
arrow
News | FDA

March 6, 2024 — Lantheus Holdings, Inc. (Lantheus), a radiopharmaceutical company, has announced that the U.S. Food and ...

Time March 06, 2024
arrow
News | Point-of-Care Ultrasound (POCUS)

February 13, 2024 — Butterfly Network, Inc., a digital health company transforming care through the power of portable ...

Time February 13, 2024
arrow
News | Information Technology

February 2, 2024 — FUJIFILM Sonosite Inc., a leader in point-of-care ultrasound (POCUS) solutions, announced the launch ...

Time February 02, 2024
arrow
News | Radiology Business

January 25, 2024 — Esaote Group, a leading Italian innovator in medical imaging, today unveiled its new brand identity ...

Time January 25, 2024
arrow
News | Interventional Radiology

January 10, 2024 — Proceedings from an expert consensus roundtable that discussed the benefits of intravascular ...

Time January 10, 2024
arrow
Subscribe Now